Disease of children caused by environmental mycobacteria

Tijdschrift voor Kindergeneeskunde

Volumn 64, Issue 6, 1996, Pages 255-265

  Grange, J M ^a   Portaels, F ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3843051400     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Portaels F. Epidemiology of mycobacterial diseases. Clinics Dermatol 1995;13:207-22.
2. Grange JM. Mycobacteria and Human Disease, Second Edition. London: Arnold. 1996.
3. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1990;9:17-215.
4. Arbeit RD, Slutsky A, Barber TW, et al. Genetic diversity of Mycobacteriam avium strains causing monoclonal and polyclonal bacteremia in patients with the acquired immunodeficiency syndrome (AIDS). J Infect Dis 1993;167:1384-90.
5. Guthertz LS, Damsker B, Bottone EJ, et al. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis 1989;160:1037-41.
6. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol 1984;57:193-211.
7. Schulze-Röbbecke R, Janning B, Fischeder R. Occurrence of mycobacteria in biofilm samples. Tubercle Lung Dis 1992;73:141-4.
8. von Reyn CF, Maslow JN, Barber TW, et al. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994;343:1137-41.
9. Katila ML, Brander E, Backman A. Neonatal BCG vaccination and mycobacterial cervical lymphadenitis in childhood. Tubercle 1987;68:291-6.
10. Romanus V. Swedish experiences 12 years after the cessation of general BCG vaccination of new borns in 1975. Bull Int Union Tuberc Lung Dis 1988;63:34-8.
11. Romanus V, Halalander HO, Wahlen P, et al. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tubercle Lung Dis 1995;76:300-10.
12. Trnka L, Dankova D, Svandova E. Six years' experience with the disccontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium - intracellulare complex. Tubercle Lung Dis 1994;75:348-52.
13. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346:1339-45.
14. Clark JE, Magee JG, Cant AJ. Non-tuberculous mycobacterial lymphadenopathy. Arch Dis Child 1995;72:165-6.
15. Eastwood JB, Duly SA, Grange JM. Tuberculosis, leprosy and other mycobacterial diseases. In: Cattell WR, ed. Infections of the Kidney and Urinary Tract. Oxford: Oxford University Press, 1995.
16. Gubler JGH, Salfinger M, von Graevenitz A. Pseudoepidemic of non-tuberculous mycobacteria due to a contaminated bronchoscope washing machine - report of an outbreak and a review of then literature. Chest 1992;101:1245-9.
17. Guimard Y, Portaels F. Pseudo-infections à mycobactéries atypiques: détection, prévention et recommendations. ARSOM Bulletin des séances 1996;42: in press.
18. Colville A. Retrospective review of culture-positive mycobacterial lymphadenitis cases in children in Nottingham, 1979-1990. Eur J Clin Microbiol Infect Dis 1993;12:192-5.
19. MacCallum P, Tolhurst JC, Buckle C, Simmons HA. A new mycobacterial infection in man. J Pathol Bacteriol 1948;60:93-122.
20. Werf TS van der, Graaf WTA van der, Groothuis DG, Knell AJ. Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans R Soc Trop Med Hyg 1989;83:410-3.
21. Josse R, Guédénon A, Darie H, et al. Les infections cutanées à Mycobacterium ulcerans: ulcères de Buruli. Médecine Tropicale 1996;55:363-73.
22. Marston BJ, Diallo MO, Horsburgh CR, et al. Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg 1995;52:219-24.
23. Meyers W, Tignokpa N, Priuli GB, Portaels F. Mycobacterium ulcerans infection (Buruli ulcer): First reported patients in To-go. Identification of etiologic agent by DNA sequencing. Brit J Dermatol 1996;134:1116-21.
24. Barker DJP. Epidemiology of Mycobacterium ulcerans infection. Trans R Soc Trop Med Hyg 1973;67:43-50.
25. Portaels F. Epidémiologie des ulcères à Mycobacterium ulcerans. Ann Soc Belge Med Trop 1989;69:91-103.
26. Muelder K, Nourou A. Buruli ulcer in Benin. Lancet 1990;336:1109-11.
27. Hockmeyer WT, Krieg RE, Reich M, Johnson RD. Further characterisation of Mycobacterium ulcerans toxin. Infect Immun 1978;21:124-8.
28. Burchard GD, Bierther M, Buruli ulcer: a clinical pathological study of 23 patients in Lambarene, Gabon. Trop Med Parasitol 1986;37:1-8.
29. Stanford JL, Revill WDL, Gunthorpe WJ, Grange JM. The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. Journal of Hygiene 1975;74:7-16.
30. Meyers WM. Mycobacterial infections of the skin. In: G. Seifert (ed.), Tropical pathology. Springer-Verlag Heidelberg 1995:291-377.
31. Linell F, Norden A. Mycobacterium balnei: a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand 1954; suppl33:1-84.
32. Aronson JD. Spontaneous tuberculosis in salt water fish. J Infect Dis 1926;39:315-20.
33. Jolly HW, Seabury JH. Infections with Mycobacterium marinum. Arch Dermatol 1972;106:32-6.
34. Collins CH, Grange JM, Noble WC, Yates MD. Mycobacterium marinum infections in man. J Hyg 1985;94:135-49.
35. Inman PM, Beck A, Brown AE, Stanford JL. Outbreaks of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969;100:141-7.
36. Borghans JG, Stanford JL Mycobacterium chelonei in abscesses after injection of diptheria-pertussis-tetanus-polio vaccine. Amer Rev Respir Dis 1973;107:1-8.
37. Jackson PG, Keen H, Noble CJ, Simmons NA. Injection abscesses due to Mycobacterium chelonei occurring in a diabetic patient. Tubercle 198;62:277-9.
38. Khooshabeh R, Grange JM, Yates MD, McCartney ACE. Casey TA. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye. Tubercle Lung Dis 1994;75:377-82.
39. Grange JM. Mycobacterial infections following heart valve replacement. J Heart Valve Dis 1992;1:102-9.
40. Franklin DJ, Starke JR, Brady MT, et al. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am J Otol 1994;15:313-20.
41. Gonzalez EP, Crosby RMN, Walker SH. Mycobacterium aquae infection in a hydrocephalic child (Mycobacterium aquae meningitis). Paediatrics 1971;48:974-7.
42. White R, Abreo K, Flanagan R, Mann JM. Non-tuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Amer J Kid Dis 1993;22:581-7.
43. Lotte A, Wasz-Höckert O, Poisson N, et al. BCG complications. Adv Tuberc Res 1984;21:107-93 and 194-245.
44. Reyn CF von, Clements J, Mann JM. HIV infection and routine childhood immunization. Lancet 1987;2:669-72.
45. Green PA, Reyn CF von, Smith RP. Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. Pediatr Inf Dis J 1993;12:615-7.
46. Grange JM, Yates MD, Pozniak A. Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in South east England: a recent increase in the number of cases. Arch Dis Childh 1995;72:516-7.
47. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59.
48. Wolinsky E. Mycobacterial lymphadenitis in children: A prospective study of 105 nontuberculous cases with long-term follow up. CID 1995;20:954-63.
49. Dawson DJ, Blacklock ZM, Kane DW. Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med J Austr 1981;2:289-90.
50. Haas WH, Kirschner P, Ziesing S, Bremer HJ, Böttger EC. Cervical lymphadenitis in a child caused by a previously unknown mycobacterium. JID 1993;167:237-40.
51. Springer B, Kirschner P, Rost-Meyer G, et al. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol 1993;31:3083-9.
52. Levine RA. Infection of the orbit by an atypical mycobacterium. Arch Ophthamol 1969;82:608-10.
53. Hoeman LH van der, Rutter FJ, Sar A van der. An unusual acid-fast bacillus causing systemic disease and death in a child. Amer J Clin Pathol 1958;29:433-45.
54. Yakovac WC, Baker R, Sweigert C, Hope JW. Fatal disseminated osteomyelitis due to an anonymous mycobacterium. J Pediatr 1961;59:909-14.
55. Rutstein RM, Cobb P, McGowan KL, et al. Mycobacterium avium-intracellulare complex infection in HIV-infected children. AIDS 1993;7:507-12.
56. Bottger EC, Teske A, Kirschner P, et al. Disseminated 'Mycobacterium genavense' infection in patients with AIDS. Lancet 1992;340:76-80.
57. Nadal D, Caduff R, Kraft R, et al. Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis 1993;12:37-43.
58. Hoop RK, Böttger EC, Ossent P, Salfinger M. Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol 1993;31:990-3.
59. Portaels F, Realini L, Bauwens L, et al. Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: an 11-year survey. J Clin Microbiol 1996;34:319-23.
60. Moulsdale MT, Harper JM, Thatcher GN, Dunn BL. Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle 1983;64:29-36.
61. Cohen RJ, Samoszuk MK, Busch D, Lagios M. Occult infections with M. intracellulare in bone marrow biopsy specimens from patients with AIDS. New Engl J Med 1983;308:1475-6.
62. Hoyt LJO, Holland B, Connor E. Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome. Pediatr Infect Dis 1992;11:354-60.
63. Levin M, Newport MJ, D'Souza S, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995;345:79-83.
64. Groot R de, Dongen JJM van, Neijens HJ, et al. Familial disseminated atypical mycobacterial infection in childhood. Lancet 1995;345:993.
65. Kuypers FY, Zwierstra RP, Langen ZJ de. De chirurgische behandeling van lymfadenitis door niet-tuberculeuze mycobacteriën bij kinderen. Ned Tijdschr Geneeskd 1995;139:2036-9.
66. Gluckman SJ. Mycobacterium marinum. Clin Dermatol 13:273-6.
67. Bonnet E, Debat-Zoguereh. Petit N, et al. Clarithromycin: A potent agent against infections due to Mycobacterium marinum. CID 1994;18-664-6.
68. Masur H and the US Public Health Service Task Force on Prophylaxis and Therapy for M. avium Complex. Recommendations on prophylaxis and therapy for disseminated M. avium complex disease in patients infected with the HIV. New Engl J Med 1993;329:898-904.
69. Yoshimura HH, Graham DY, Estes MK, Merkal RS. Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization. J Clin Microbiol 1987;25:45-51.
70. Rook GAW, Stanford JL. Slow bacterial infections or autoimmunity. Immunol Today 1992;13:160-3.
71. Grosset J, Mouton Y. Is PCR a useful tool for the diagnosis of tuberculosis in 1995? Tubercle Lung Dis 1995;76:183-4.
72. Kirschner P, Springer B, Vogel U, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol 1993;31:2882-9.